The synthesis of optically pure (R)-and (S)-2-methyl-[ 3,3,3? H3 ] alanines of biological interest is described. The stereochemistry of the reaction of the lithio derivative of (R)-(-)-2,5-dimethoxy-3-benzyl-3-methyl-3,6-dihydropyrazine with alkyl and deuterated alkyl iodides is discussed. The configuration of the newly formed center of chirality in (R)-and (S)-2-methyl-[3,3,3? H3 1 alanines is derived from H NMR. 
Amino acids optically active due to isotopic substitution of deuterium or I3C atoms are gaining increasing importance in research and practice as probes for biosynthesis and interconversion of various amino acids as well as NMR probes for peptide binding and dynamics (1 -3) .
Schollkopf et al. (4, 5 ) have recently reported on the enantio-selective synthesis of various nonproteinogenic amino acids starting with bis-lactim ethers of cyclo [LVal-Gly] and cyclo[(S) -0,O -dimethyl -QI -methyldopaGly] . These bis-lactim ethers react with butyllithium in tetrahydrofuran at -78°C to give the lithio derivatives which are condensed with alkyl, 2-alkenyl or 2-alkynyl halides, ketones, aldehydes and halomethylbenzyl ethers to form the appropriate adducts in high diastereomeric excess (> 95%). In all cases studied, the lithium derivative of the bis-lactim ethers containing an L(S) amino acid center at the C-3 is approached by the electrophiles trans to the bulky substituent in the C-3 position to give the R configuration at the C-6 position.
We have utilized these methods to prepare (R)-and (S)-2-methyl-[3,3,3-' H3] alanines for incorporation into certain peptides in order to restrict their various conformational degrees of freedom (6) and at the same time utilize the deuterated methyl group in H NMR studies to investigate the molecular dynamics of these peptides and their binding to other macromolecular molecules (7) .
We chose as our chiral agent (R)-(+)-2-methyl-3-phenylalanine 1, which was prepared from phenylacetone (8) in a convenient fourstep sequence in 49% overall yield by a modified asymmetric Strecker synthesis first described by Weinger and coworkers (9) . This amino acid was chosen because it bears an a substituent and therefore the cyclo [a-methylphe-gly] derived can be alkyhted only at the C-6 position. The phenylalanine derivative was esterified with methanolic HC1 (10) and the resulting methyl ester 2 condensed (1 1) with Nt-Boc-glycine giving the dipeptide methyl ester 3. Following the procedure of Nitecki et al. (12) , the dipeptide methyl ester 3 was cyclized, after treating with formic acid, by boilin in a 2:1 mixture of sec-butanol and toluene to yield the 2,5-diketopiperazin.e 4. The piperazine 4 was then converted into the bis-lactim ether 5 (see Scheme 1) by treatment with trimethyloxonium tetrafluoroborate (1 3) .
The bis-lactim ether 5 reacted directly with 1 equiv. of butyllithium in tetrahydrofuran (or 1,2-dimethoxyethane) at -78OC to form the lithium derivative of 5 , a resonance-stabilized diazapentadienyl anion, which is regarded as an ion pair. This lithio derivative reacted with alkyl iodides to afford a mixture of diastereomers 6 and 7**. The diastereomer 6a, in which the alkyl group (CH,) has entered trans, with respect to the benzyl group at C-3, was the predominant isomer (the ratio of truns:cis approach for alkylation with CH31 is 80:20 E *One equivalent of morpholine was added to improve the cyclization, otherwise the standard Nitecki conditions gave poor yields. The (6s) configuration of 6a was deduced from the ' H NMR spectrum. The bis-lactim ethers 6 and 7 adopt a boat shape for the heterocycle (1 3) and the folded conformation (14) for the benzyl group. In the 'H NMR spectra, the hydrogen atom at the C-6 carbon of 6a appeared at 6 = 3.10, while the hydrogen atom of 7a appeared at 6 = 3.74. The upfield shift of 0.7 ppm of the 6-hydrogen is due to the shielding effects of the aromatic ring in the C-3 position (15) in 6a (compared to that in 7a). This is consistent with the trans addition of the methyl group in the alkylation step, i.e., induction of the S configuration at C-6 in 6a.
Additionally, the ' H NMR spectrum of 6a showed a signal at 6 = 1.1 1 for the C-6 methyl, whereas the C-6 methyl signal in 7a appeared at 6 = 0.24. The upfield shift of the C-6 methyl in the minor diastereomer 7a (compared to that in 6a) is also consistent with the report of Woodard (1 5) and is in agreement with the 6 S configuration for 6a. Similarly, the 6 s configuration for 6b (alkylation with CD3 I) can 2-methyl-[3-13 C] alanines could be synthesized in a similar manner using unlabeled methyliodide and ["C] methyliodide.
In conclusion, we synthesized the his-lactim alanine, respectively. However, in the present study, the diastereomers did not need to be separated since the configuration at C-6 would be lost on lithiation in the next step.
The mixture of monoalkylated products 6a and 7a was further reacted with butyllithium in tetrahydrofuran at -778°C to form a single anion (since the C-6 carbon is now sp2, there is no difference in the stereochemistry of the anions formed from 6a and 7a) which was attacked by [2 H3 1 methyliodide (see Scheme 2) to give exclusively the (3R, 6 s ) diastereomer 8a
(% de >95% as determined by ' H NMR). The second alkyl group entered trans with respect to the bulky benzyl group in the C-3 position.
The (3R, 6R) diastereomer 8 b was prepared by reversing the order of alkylation, i.e. ['H3]-methyliodide, followed by unlabeled methyliodide. The 'H NMR of both 8a and 8b showed only one C-6 methyl group (6 = 0.31 and 6 = 1.10 respectively) and, hence, the diastereomeric excess of both dialkylated products 8a and 8b was assumed to be >95%.
The characteristic upfield shift (0.8 ppm) of the 6-CH3 signal (6 = 0.31) in 8a compared to that (6 = 1.1) in 8b was in agreement with the ( 6 s ) configuration in 8a and the (6R) configuration in 8b (1 5) .
The 3,6-dihydropyrazines 8a and 8b, on hydrolysis with 0.25 N HCl (4equiv.) at room temperature, were cleaved to give (R)-2-methyl-3-phenylalanine methyl ester 2 and either (S)- The CD31 (99 + atom%) was purchased from Aldrich Chemical and used without further purification.
Column chromatography was performed using E. Merck silica gel 60, 70-230 mesh ASTM, elutions being carried out with 19:l hexane/ethyl acetate (v:v) followed by 9: 1 hexane/ethyl acetate unless otherwise noted. Analytical thin layer chromatography was performed on Analtech, 20 x 20cm plates precoated with silica gel G. Tetrahydrofuran and 1,2-dimethoxyethane wete distilled from LiA1H4 immediately prior to use. Dichloromethane was distilled from P205 under nitrogen. All organic solvent extractions were dried with Na2 SO4 and removed in vacuo using a rotary evaporator (water aspirator vacuum) unless otherwise stated. Elemental analyses were 
(R)-(+)-N-(N-tert .-butoxycarbonyZglycinyl)2-methyl-3-phenylalanine methyl ester (3)(11)
To a stirred solution of (R)-(-)-2-methyl-3-phenylalanine methyl ester 2 (4.83 g, 25 mmol) in dry dichloromethane (30ml) at 0°C was added a solution of N-2,2-dimethylethyloxycarbonylglycine (4.38 g, 25 mmol) and N,N'-dicyclohexylcarbodiimide (5.16 g, 25 mmol) in dry dichloromethane (20 ml) followed by the addition of 4-dimethylaminopyridine (DMAP) (0.61 g, 5 mmol). The reaction mixture was allowed to stir at 0°C for 4 h and at room temperature overnight. The urea which formed was removed by filtration and the filtrate evaporated to yield an oily residue. The residue was dissolved in ether (l00ml) and washed successively with 5% citric acid, a saturated NaHC03 solution, and water. The organic layer was evaporated to yield the crude peptide 3 as a viscous oil. The oily product was purified by 582 column chromatography with ethyl acetate/ hexane (3:2) as eluant to yield 7.2g (82.2%);
[a} = + 45.4" (c = 1.6, methanol), H NMR 9H, C(CH3)3), 2.98 and 3.23 (d, AB, J = 13.2 Hz, C6H5CHz), 3.53 (dd merged into t, J = (DMSO-d6) 6 1.21 (s, 3H, C-CH3), 1 
(R)-(-)-3-Methyl-3-benzyl-2,5-diketopiperazine
The procedure of Nitecki and coworkers (12) for converting t-Boc-pro t ec t ed dipe p tide methyl ester into cyclic dipeptide was modified as follows: the r-Boc dipeptide methyl ester 3 (7. 0g, 20.0 mmol) was dissolved in formic acid (125 mL) and stirred for 2 h under a drying tube. The solution was concentrated in vacuo (bath temperature < 30°C) and the residue triturated several times with dry ether to
(4)
Enantioselective synthesis of alanines 2.0 mmol) in dry tetrahydrofuran (or better 1,2-dimethoxyethane) (5 mL) under nitrogen at -78°C was added by syringe a 1.6N solution (1.4 mL, 2.2 mmol) of butyllithium in hexane and the mixture stirred for 30-45 min to insure formation of the anion. Then a precooled solution of methyl iodide (310mg, 2.2 mmol) in dry THF (5 mL) was added and stirring continued for 8 h at -78°C. The mixture was allowed to warm to room temperature and the solvent removed in vacuo to give a residue which was dissolved in diethyl ether and washed with Na phosphate buffer, pH = 7 (3 x 25mL). After evaporation of the solvent, the residual product, 430 mg (82.6%), a mixture of 6a: 7a in the ratio of 80:20 (trans: cis approach) in THF and 85: 15 in dimethoxyethane, was purified by column chromatography to yield 6a as an oil; IR (film) 1695 cm-' ( C = N ) , ' H NMR (DMSO-d6) 6 1.11 To a solution of the formate salt in sec-butanol (200 mL) and toluene (100 mL) was added 1.5 g (17.2mmol) of morpholine" and the whole mixture heated at reflux (96°C) for 2f h. After most of the solvent was removed, the solution was cooled to 0°C and the resulting solid filtered. The crude product was purified by recrystallization from methanol to give 2.8 g (64.1%) of the title compound, nip 302-304"C, 
(R)-(--)-2,5-Dimethoxy-3-benzyl-3methyl-3,6-dihydropyrazine (5)
A mixture of the diketopiperazine 4 (4.37g, 20mmol) and 7.4g (50mmol) of trimethyloxonium tetrafluoroborate in l 0 0 m L of dry dichloromethane was vigorously (mechanically) stirred at 40°C for 72 h. The reaction mixture was cooled to room te erature and a solution of 6 g of potassium carbdnate in 25mL of water added, the organic layer separated and the aqueous layer extracted with dichloromethane (3 x 50mL). The combined organic extracts were evaporated to give a crude! residue which was purified by column chromatography 
